财中社2月5日电圣诺医药-B(02257)发布公告,宣布非执行董事陆阳因希望投入更多时间于其他事务,自2025年2月5日起辞任其非执行董事、董事会提名委员会成员、集团荣誉首席科学官及授权代表职务。同时,陆阳将被任命为集团荣誉科学顾问。公告中提到,陆阳确认与董事会没有意见分歧,也没有其他需股东关注的事项。
此外,董事会还宣布黄梦莹自2025年2月5日起被任命为提名委员会成员及授权代表。公告中提到,董事会成员包括执行董事潘洪辉、非执行董事章建康及独立非执行董事黄梦莹和于常海。
(文章来源:财中社)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.